"Voice is the New Blood": A Discourse Analysis of Voice AI Health-Tech Start-up Websites

Alden Blatter¹Hortense Gallois¹Emily Evangelista²Yael Bensoussan²Bridge to AI Consortium³Jean-Christophe Bélisle-Pipon^1*

• ¹Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada
• ²Department of Otolaryngology - Head & Neck Surgery, Morsani College of Medicine, USF Health, Tampa, Florida, United States
• ³National Institutes of Health (NIH), Bethesda, Maryland, United States

Voice as a biomarker has emerged as a transformative field in health technology, providing non-invasive, accessible, and cost-effective methods for detecting, diagnosing, and monitoring various conditions. Start-ups are at the forefront of this innovative field, developing and marketing clinical voice AI solutions to a range of healthcare actors and shaping the field's early development. However, there is limited understanding of how start-ups in this field frame their innovations, and address-or overlook-critical socio-ethical, technical, and regulatory challenges in the rapidly evolving field of digital health. Method: This study uses discourse analysis to examine the language on the public websites of 25 voice AI health-tech start-ups. Grounded in constitutive discourse analysis, which asserts that discourse both reflects and shapes realities, the study identifies patterns in how these companies describe their identities, technologies, and datasets. Results: The analysis shows start-ups consistently highlight the efficacy, reliability, and safety of their technologies, positioning them as transformative healthcare solutions. However, descriptions of voice datasets used to train algorithms vary widely and are often absent, reflecting broader gaps in acoustic and ethical standards for voice data collection and insufficient incentives for start-ups to disclose key data details. Discussion: Start-ups play a crucial role in the research, development, and marketization of voice AI health-tech, prefacing the integration of this new technology into healthcare systems. By publicizing discourse around voice AI technologies at this early stage, start-ups are shaping public perceptions, setting expectations for end-users, and ultimately influencing the implementation of voice AI technologies in healthcare. Their discourse seems to strategically present voice AI health-tech as legitimate by using promissory language typical in the digital health field and showcase the distinctiveness from competitors. This analysis highlights how this double impetus often drives narratives that prioritize innovation over transparency. We conclude that the lack of incentive to share key information about datasets is due to contextual factors that start-ups cannot control, mainly the absence of clear standards and regulatory guidelines for voice data collection. Addressing these complexities is essential to building trust and ensuring responsible integration of voice AI into healthcare systems.